CytomX Therapeutics, Inc.
CTMXDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 2 past
No catalysts found.
How CTMX's past catalysts played out
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in CytomX Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in CytomX Therapeutics, Inc.'s (CTMX) pipeline across Phase 2. Its lead program is CX-2009 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CytomX Therapeutics, Inc.'s next FDA catalyst?→
CytomX Therapeutics, Inc.'s (CTMX) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CTMX biotech catalysts?→
Add CTMX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CytomX Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.